account_balance
Investment manager · 13F filer · SEC CIK 1792206
Foresite Capital Management V, LLC
Reported value$362Mas of Jun 30, 2026
Positions9 1 new, 1 sold out
Top 10 weight100.0%ALMS alone is 46%
FiledAug 1445 days after quarter end
Portfolio · as of Jun 30, 2026
Where the money is
New or addedTrimmedHeld
This fund reports 9 stocks.
ALMSAlumis Inc.
45.8%
CGONCG Oncology, Inc.
21.2%Added +7%
IRONDisc Medicine, Inc.
7.6%
HIMSHims & Hers Health, Inc.
7.1%
PHVSPharvaris N.V.
6.3%Added +242%
EIKNEikon Therapeutics, Inc.
4.8%
ODTXOdyssey Therapeutics, Inc.
3.7%New
LYELLyell Immunopharma, Inc.
1.8%
NRIXNurix Therapeutics, Inc.
1.8%
ALMSAlumis Inc.
45.8%
CGONCG Oncology, Inc.
21.2%Added +7%
IRON7.6%HIMS7.1%PHVS6.3%EIKN4.8%ODTX3.7%LYELNRIXBox size is the share of the fund. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
Show the top 9 as a list
ALMS Alumis Inc. 45.8% HeldCGON CG Oncology, Inc. 21.2% Added +7%IRON Disc Medicine, Inc. 7.6% HeldHIMS Hims & Hers Health, Inc. 7.1% HeldPHVS Pharvaris N.V. 6.3% Added +242%EIKN Eikon Therapeutics, Inc. 4.8% HeldODTX Odyssey Therapeutics, Inc. 3.7% NewLYEL Lyell Immunopharma, Inc. 1.8% HeldNRIX Nurix Therapeutics, Inc. 1.8% Held
What changed